Welcome - Debiopharm, We develop for patients

About us
Welcome
At a glance
Mission & Values
History
Let's meet
Debiopharm Group
Debiopharm International S.A.
Debiopharm Research & Manufacturing S.A.
Debiopharm Investment S.A.
Debiopharm Innovation Fund S.A.
GenePOC Inc.
Scientific Awards & Grants
Debiopharm Academy
Entrepreneurship
Social Responsibility
Contact Center
Our Headquarter is located in Lausanne/Switzerland.
Phone +41 (0)21 321 0111
To find the numbers of all the Debiopharm Group's companies, use this page.
Business
Business Model
Partnering
Pipeline
Translational Medicine
Drug Discovery & Preclinical
Clinical development
Innovative drug delivery and formulation
Manufacturing & Quality Assurance
Regulatory
Product Pipeline
More info
Products
Eloxatin® / Elplat® / Dacotin® / Dacplat®
Oxaliplatin is a diaminocyclohexane (DACH) platin for the treatment of colorectal cancer.
Decapeptyl® / Trelstar® / Pamorelin® / Neo Decapeptyl®/Triptodur®
1 to 6 month formulation for the treatment of prostate cancer, of endometriosis, precocious puberty, uterine fibroids, ovarian cancer, breast cancer, female infertility.
Salvacyl® / Moapar®
For the treatment of severe sexual deviations.
We develop for patients
More infos
Careers
Working at Debiopharm
Approximately 400 people of more than 18 nationalities from Europe, North and South America, Africa and Asia are employed at Debiopharm Group™ on its sites.
More info
Jobs
Senior Clinical Trial ManagerLausanne
Commercial Alliance Management SpecialistLausanne
Open positions Spontaneous application
Media
Corporate Profile
Press Releases
Events
Contact media relations
Publications
Logo & Media Download Area
Videos
Latest news
Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and TesiDebiopharm Innovation Fund S.A. - 05 April 2018 All News
Debiopharm TV

Latest news

19 February 2018

international

GenePOC launches its revogene™ instrument and GBS LB test in Canada

Debiopharm's vision of healthcare is not limited to making new medicines available. We strongly believe that you can be an actor in your own medical care. Your safety is our top priority.

MORE ABOUT CLINICAL TRIALS

April 20, 2018

ECCMID 2018

WATCH ALL EVENTS

A unique business model
for success

Discover our business model

We value strong
long-lasting relationships

Discover our partnerships

Debiopharm Group
presented at a glance

Follow our
Product Pipeline

Discover
Debiopharm TV

Social & Corporate
Responsibility

Contact Center

Product Pipeline

We develop for patients

Working at Debiopharm

Jobs

Latest news

Debiopharm TV

Add this to your social network !